![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Javier Garcia Perlaza, Rima Aziziyeh, Anna Zhou, Vitor De Sousa Barbosa, Jenny Amaya, Joaquin Caporale, Monica Elena Alva, Juan Forero, Straus Tanaka, Gaurav Suri & David Garcia. (2021) The burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and Mexico. Journal of Medical Economics 24:1, pages 983-992.
Read now
Read now
Alison Stopeck, Adam Brufsky, Lisa Kennedy, Sumi Bhatta, Debajyoti Bhowmik, Jacqueline Buchanan, Nicolas Despiegel & Guy Hechmati. (2020) Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. Journal of Medical Economics 23:1, pages 37-47.
Read now
Read now
Evangelos Terpos, Aurelien Jamotte, Alexandra Christodoulopoulou, Marco Campioni, Debajyoti Bhowmik, Lisa Kennedy & Wolfgang Willenbacher. (2019) A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy. Journal of Medical Economics 22:8, pages 766-776.
Read now
Read now
David Henry, Roger von Moos, Jean-Jacques Body, Alex Rider, Jonathan De Courcy, Debajyoti Bhowmik, Francesca Gatta, Guy Hechmati & Yi Qian. (2019) Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States. Current Medical Research and Opinion 35:3, pages 375-381.
Read now
Read now
Debajyoti Bhowmik, Dionne M. Hines, Michele Intorcia & Rolin L. Wade. (2018) Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database. Journal of Medical Economics 21:6, pages 622-628.
Read now
Read now
Noopur Raje, Garson David Roodman, Wolfgang Willenbacher, Kazuyuki Shimizu, Ramón García-Sanz, Evangelos Terpos, Lisa Kennedy, Lorenzo Sabatelli, Michele Intorcia & Guy Hechmati. (2018) A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America. Journal of Medical Economics 21:5, pages 525-536.
Read now
Read now
Umberto Restelli, Giovanni Luca Ceresoli, Davide Croce, Laura Evangelista, Lorenzo Stefano Maffioli, Letizia Gianoncelli & Emilio Bombardieri. (2017) Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study. Cancer Management and Research 9, pages 789-800.
Read now
Read now
Joaquim Cristino, Jíndřich Finek, Petra Jandova, Martin Kolek, Bálint Pásztor, Christina Giannopoulou, Yi Qian, Tomas Brezina & Mickael Lothgren. (2017) Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic. Journal of Medical Economics 20:8, pages 799-812.
Read now
Read now
J. Pereira, J.-J. Body, O. Gunther, H. Sleeboom, G. Hechmati, N. Maniadakis, E. Terpos, Y. P. Acklin, J. Finek & R von Moos. (2016) Cost of skeletal complications from bone metastases in six European countries. Journal of Medical Economics 19:6, pages 611-618.
Read now
Read now
May Hagiwara, Thomas E. Delea & Karen Chung. (2014) Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases. Journal of Medical Economics 17:3, pages 223-230.
Read now
Read now
Articles from other publishers (37)
Francesca Fiorentino & Paolo Di Rienzo. (2023) Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy. Global & Regional Health Technology Assessment 10, pages 29-39.
Crossref
Crossref
Julia Simões Corrêa Galendi, Sin Yuin Yeo, Holger Grüll, Grischa Bratke, Dennis Akuamoa-Boateng, Christian Baues, Clemens Bos, Helena M. Verkooijen, Arim Shukri, Stephanie Stock & Dirk Müller. (2022) Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastases. Frontiers in Oncology 12.
Crossref
Crossref
Dawid Ciechanowicz, Daniel Kotrych, Filip Dąbrowski & Tomasz Mazurek. (2022) Trends in Diagnosis and Surgical Treatment of Bone Metastases among Orthopedic Surgeons. Journal of Clinical Medicine 11:15, pages 4284.
Crossref
Crossref
Chin-Yao Shen, Philip Chun-Ming Au, Yeon-Hee Baek, Ching-Lung Cheung, Wei-Pang Chung, Ju Hwan Kim, Nora J. Kleinman, Tai-Chung Lam, Tzu-Chi Liao, Tzu-Chieh Lin, Ju-Young Shin, Chor-Wing Sing, Ian Chi Kei Wong & Edward Chia-Cheng Lai. (2022) Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study. BioDrugs 36:3, pages 381-392.
Crossref
Crossref
Roger von Moos, Katie Lewis, Lucy Massey, Andrea Marongiu, Alex Rider & Anouchka Seesaghur. (2022) Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in Europe. Bone 154, pages 116243.
Crossref
Crossref
Chirayu M. Patel, Thaddeus J. Wadas & Yusuke Shiozawa. (2021) Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases. Molecules 26:8, pages 2162.
Crossref
Crossref
Jéssica S. Barbosa, Susana Santos Braga & Filipe A. Almeida Paz. (2020) Empowering the Medicinal Applications of Bisphosphonates by Unveiling their Synthesis Details. Molecules 25:12, pages 2821.
Crossref
Crossref
AnneMarthe Mjelstad, Gustav Zakariasson & Antonis Valachis. (2019) Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration. Supportive Care in Cancer 27:10, pages 3859-3867.
Crossref
Crossref
Yeon-Hee Baek, Ha-Lim Jeon, In-Sun Oh, Hyowon Yang, Jeehye Park & Ju-Young Shin. (2019) Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study. Cancer Epidemiology 61, pages 104-110.
Crossref
Crossref
Roger von Moos, Luis Costa, Eva Gonzalez-Suarez, Evangelos Terpos, Daniela Niepel & Jean–Jacques Body. (2019) Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody. Cancer Treatment Reviews 76, pages 57-67.
Crossref
Crossref
Jean-Jacques Body, Roger von Moos, Alex Rider, Pamela Hallworth, Debajyoti Bhowmik, Francesca Gatta, Guy Hechmati & Yi Qian. (2019) A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe. Journal of Bone Oncology 14, pages 100212.
Crossref
Crossref
Maria Silvia Spinelli & Andrea Piccioli. 2019. Management of Bone Metastases. Management of Bone Metastases
115
122
.
Yi Qian, Jorge Arellano, Francesca Gatta, Guy Hechmati, A. Brett Hauber, Ateesha F. Mohamed, Amit Bahl, Roger von Moos & Jean-Jacques Body. (2018) Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom. BMC Health Services Research 18:1.
Crossref
Crossref
Kurt Miller, Günther G. Steger, Daniela Niepel & Diana Lüftner. (2018) Harnessing the potential of therapeutic agents to safeguard bone health in prostate cancer. Prostate Cancer and Prostatic Diseases 21:4, pages 461-472.
Crossref
Crossref
Qizhou Zhang, Kunyao Zhang, Bing Xie, Yimin Ren, Guoliang Li, Liping Zhang, Aijing Wang & Yang Li. (2018) Analysis of curative effect of I 125 implantation combined with radiofrequency ablation in treating bone metastases. Journal of Bone Oncology 11, pages 23-26.
Crossref
Crossref
Roger von Moos, Jean-Jacques Body, Alex Rider, Jonathan de Courcy, Debajyoti Bhowmik, Francesca Gatta, Guy Hechmati & Yi Qian. (2018) Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries. Journal of Bone Oncology 11, pages 1-9.
Crossref
Crossref
Roger von Moos, Jean-Jacques Body, Oliver Guenther, Evangelos Terpos, Yves Pascal Acklin, Jindrich Finek, João Pereira, Nikos Maniadakis, Guy Hechmati, Susan Talbot & Harm Sleeboom. (2018) Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study. Journal of Bone Oncology 10, pages 49-56.
Crossref
Crossref
Takamitsu Inoue & Tomonori Habuchi. 2018. Hormone Therapy and Castration Resistance of Prostate Cancer. Hormone Therapy and Castration Resistance of Prostate Cancer
327
338
.
I. Duran, M.G. Fink, A. Bahl, H. Hoefeler, A. Mahmood, D. Lüftner, H. Ghazal, R. Wei, K.C. Chung, G. Hechmati, J. Green & C. Atchison. (2017) Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study. European Journal of Cancer Care 26:6, pages e12452.
Crossref
Crossref
Umberto Restelli, Luca Dellavedova, Davide Croce & Lorenzo Maffioli. 2017. Bone Metastases from Prostate Cancer. Bone Metastases from Prostate Cancer
271
279
.
Grzegorz Guzik. (2016) Results of the treatment of bone metastases with modular prosthetic replacement—analysis of 67 patients. Journal of Orthopaedic Surgery and Research 11:1.
Crossref
Crossref
Jean-Jacques Body, Yves Pascal Acklin, Oliver Gunther, Guy Hechmati, João Pereira, Nikos Maniadakis, Evangelos Terpos, Jindrich Finek, Roger von Moos, Susan Talbot & Harm Sleeboom. (2016) Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries. Journal of Bone Oncology 5:4, pages 185-193.
Crossref
Crossref
Rogier Lange, Rob ter Heine, Russ (FF) Knapp, John M.H. de Klerk, Haiko J. Bloemendal & N. Harry Hendrikse. (2016) Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases. Bone 91, pages 159-179.
Crossref
Crossref
Jean-Jacques Body, João Pereira, Harm Sleeboom, Nikos Maniadakis, Evangelos Terpos, Yves Pascal Acklin, Jindrich Finek, Oliver Gunther, Guy Hechmati, Tony Mossman, Luis Costa, Wojciech Rogowski, Hareth Nahi & Roger von Moos. (2015) Health resource utilization associated with skeletal-related events: results from a retrospective European study. The European Journal of Health Economics 17:6, pages 711-721.
Crossref
Crossref
Francesca Vignani, Valentina Bertaglia, Consuelo Buttigliero, Marcello Tucci, Giorgio V. Scagliotti & Massimo Di Maio. (2016) Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. Cancer Treatment Reviews 44, pages 61-73.
Crossref
Crossref
Alberto Bazzocchi, Alessandro Napoli, Beatrice Sacconi, Giuseppe Battista, Giuseppe Guglielmi, Carlo Catalano & Ugo Albisinni. (2016) MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics. The British Journal of Radiology 89:1057, pages 20150358.
Crossref
Crossref
. 2016. Diagnostic Imaging: Musculoskeletal Trauma. Diagnostic Imaging: Musculoskeletal Trauma
12
17
.
Robert U. Ashford & R. Lor Randall. 2016. Metastatic Bone Disease. Metastatic Bone Disease
3
11
.
Miguel Ángel Seguí, Ignacio Durán, Celia Roldán, Itziar Oyagüez, Miguel Ángel Casado, Laura Gutiérrez, José Antonio Gasquet & Dolores Isla. (2014) Análisis del impacto presupuestario de denosumab para la prevención de eventos relacionados con el esqueleto en adultos con metástasis óseas de tumores sólidos en España. PharmacoEconomics Spanish Research Articles 12:3, pages 83-92.
Crossref
Crossref
Seil Sohn, Jinhee Kim, Chun Kee Chung, Na-Rye Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn & Sung Hwan Kim. (2015) Nationwide epidemiology and healthcare utilization of spine tumor patients in the adult Korean population, 2009–2012. Neuro-Oncology Practice 2:2, pages 93-100.
Crossref
Crossref
Maria Caterina Cavallo, Alessandra Cheli, Simone Gerzeli, Claudio Pelosi, Carla Rognoni & Santini Santini. (2015) Impatto economico della gestione degli eventi correlati all'apparato scheletrico (SREs) in pazienti con metastasi ossee da tumori solidi nelle regioni italiane. MECOSAN:91, pages 43-59.
Crossref
Crossref
Marcel-Philipp Henrichs, Juliane Krebs, Georg Gosheger, Arne Streitbuerger, Markus Nottrott, Tim Sauer, Steffen Hoell, Gurpal Singh & Jendrik Hardes. (2014) Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstruction. World Journal of Surgical Oncology 12:1.
Crossref
Crossref
VITO LORUSSO, IGNACIO DURAN, CRISTINA GARZON-RODRIGUEZ, DIANA LÜFTNER, AMIT BAHL, JOHN ASHCROFT, GUY HECHMATI, RACHEL WEI, EMMA THOMAS & HERBERT HOEFELER. (2014) Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study. Molecular and Clinical Oncology 2:5, pages 701-708.
Crossref
Crossref
Amit Bahl, Herbert Hoefeler, Ignacio Duran, Guy Hechmati, Cristina Garzon-Rodriguez, John Ashcroft, Vito Lorusso, Prayashi Ghelani, Rachel Wei, Emma Thomas & Diana Lüftner. (2014) Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study. Journal of Clinical Medicine 3:3, pages 883-896.
Crossref
Crossref
Prue Cormie, Daniel A. Galvão, Nigel Spry, David Joseph, Dennis R. Taaffe & Robert U. Newton. (2014) Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study. Supportive Care in Cancer 22:6, pages 1537-1548.
Crossref
Crossref
H. Hoefeler, I. Duran, G. Hechmati, C. Garzon Rodriguez, D. Lüftner, J. Ashcroft, A. Bahl, C. Atchison, R. Wei, E. Thomas & V. Lorusso. (2014) Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective – prospective observational study – a cohort from 4 European countries. Journal of Bone Oncology 3:2, pages 40-48.
Crossref
Crossref
P Cormie, R U Newton, N Spry, D Joseph, D R Taaffe & D A Galvão. (2013) Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer and Prostatic Diseases 16:4, pages 328-335.
Crossref
Crossref